Exclusive-Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
Go back to Exclusive-Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 603.29 -13.81 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $617.10 | 52 Week High | $160.68 | |||
| Open | $619.00 | 52 Week Low | $119.75 | |||
| Day High | $621.00 | P/E | 172.37 | |||
| Day Low | $603.07 | EPS | $3.50 | |||
| Volume | 463,684 | |||||
